|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 700 |
City | WASHINGTON, DC |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 89177-12
|
||||||||
|
6. House ID# 366750000
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Barbara Cosgriff, Sr. Vice President, Public Policy and External Affairs |
Date | 04/20/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Health Information Technology, ARRA Privacy and Security Rules, Biogenerics, Comparative Effectiveness, Chronic Care Management, Health Care Reform
HR 1 - American Recovery and Reinvestment Act of 2009; Title VIII Departments of Labor, Health and Human Services, and Education, and Related Agencies, Healthcare Research and Quality and Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections
HR 1321 and S. 391 - Health Americans Act; all sections
HR 1427 and S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act; all sections
HR 1548 - Pathway for Biosimilars Act; all sections
HR 3200 - America's Affordable Choices Act; all sections
HR 3596 - Health Insurance Industry AntiTrust Enforcement Act of 2009; all sections
HR 3962 - Affordable Healthcare for America Act; all sections
HR 3590 - Patient Protection and Affordable Care Act; all sections
HR 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections
S 1793 - America's Healthy Future Act of 2009; all sections
HR 4873 and S. Con. Res. 13 - Healthcare and Education Reconciliation Act of 2010; all sections
HR 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Peter |
Begans |
|
|
|
Jody |
Allen |
|
|
|
Nicolette |
Tapay |
|
senior policy advisor, Sen. Ron Wyden |
|
Lillian |
German |
|
senior counsel, House Judiciary Committee |
|
Andrea |
Bergman |
|
|
|
Ryan |
Sadler |
|
|
|
Heather |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Health Care Reform, Medicare Part D, Antitrust Exemption for Independent Pharmacists, IVIG Payments, Medicare Demonstration Project for Durable Medical Equipment, Importation of Prescription Drugs, Home Infusion
HR 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections
HR 1204 - Community Pharmacy Fairness Act of 2009; all sections
HR 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program; all sections
HR 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections
HR 3962 - Affordable Health Care for America Act; all sections
HR 3590 - Patient Protection and Affordable Care Act; all sections
S1793 - America's Healthy Future Act of 2009; all sections
HR 4752 - Medicare Prescription Drug Price Negotiation Act of 2010
HR 4872 - Healthcare and Education Reconciliation Act of 2010; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Federal Trade Commission (FTC), Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Peter |
Begans |
|
|
|
Jody |
Allen |
|
|
|
Nicolette |
Tapay |
|
senior policy advisor, sen. ron wyden |
|
Lillian |
German |
|
senior counsel, house judiciary committee |
|
Andrea |
Bergman |
|
|
|
Ryan |
Sadler |
|
|
|
Heather |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 1- American Recovery and Reinvestment Act of 2009; Title XIII - Health Information Technology for Economic and Clinical Health Act or the HITECH Act; all sections; Electronic Prescribing; Mail Order Pharmacy
HR 4199 - Patient Health and Real Medication Access Cost Savings Act; all sections
HR 4489 - The FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act of 2010; all sections
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Barbara |
Cosgriff |
|
|
|
Peter |
Begans |
|
|
|
Jody |
Allen |
|
|
|
Nicolette |
Tapay |
|
senior policy advisor, sen. ron wyden |
|
Lillian |
German |
|
senior counsel, house judiciary committee |
|
Andrea |
Bergman |
|
|
|
Ryan |
Sadler |
|
|
|
Heather |
Stewart |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
Accredo Health Group, Inc. |
|
|
||||||||||||
Liberty Medical Supply, Inc. |
|
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |